Business Wire3d
U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
In PURPOSE 1 (NCT04994509), data showed twice-yearly lenacapavir demonstrated zero infections in the lenacapavir group and 100% risk reduction and superiority compared to background HIV incidence ...
PharmiWeb2d
U.S. FDA Accepts Gilead’s New Drug Applications for Twice-Yearly Lenacapavir for HIV Prevention Under Priority Review
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) submissions for lenacapavir—the company’s twice-yearly ...
This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under ...
Marketplace4d
The foreign aid freeze is affecting lifesaving HIV/AIDS treatment
We need to ensure that new HIV infections are halted. Safo: Can you explain how aid flows? Because it’s not a question of, necessarily, the government provides the money and then it’s spent.
HIV stigma tied to moral judgments, complicating destigmatization efforts
Persistence of stigma toward people living with HIV has puzzled scientists looking at the numerous destigmatization campaigns ...
eLife2d
Multi-Omics Single-Cell Analysis Reveals Key Regulators of HIV-1 Persistence and Aberrant Host Immune Responses in Early Infection
This study provides evidence that single-cell multi-omics profiling can reveal key regulators of HIV-1 persistence and early immune dysregulation, particularly implicating KLF2 and Th17 cells as major ...
Science Daily3d
HIV and AIDS News
Kidney Transplantation Among Those With HIV Infections Shown Safe and Effective, Study Suggests Oct. 17, 2024 — It is just as safe and effective for people with HIV in need of kidney ...
Nature2d
AI tool diagnoses diabetes, HIV and COVID from a blood sample
One-shot’ approach that uses machine learning to screen immune cells could help to detect conditions with overlapping ...
NanoViricides, Inc. Has Filed its Quarterly Report
Broad-Spectrum Antiviral NV-387 Phase II Clinical Trial Responding to MPox Pandemic in Africa, Readying to Tackle Bird Flu SHELTON, CT / ACCESS ...
CNN6d
How Trump’s policies could reverse decades of progress in Latin America’s HIV response
It was nearly 30 years ago when Rosember Lopez received a life-altering diagnosis: He was HIV positive. With scant government resources for HIV support at the time in Mexico, Lopez joined advocacy ...
Houston Chronicle3d
Trump's foreign aid freeze halted a crucial program fighting HIV in Africa. Here's what's at stake
HARARE, Zimbabwe (AP) — Florence Makumene held a plastic container of HIV medication and wondered if it would be her last as fears swelled of a return to a time decades ago when millions across ...
Newsday5d
South African NGOs worry Trump's aid freeze will cause HIV patients to default on treatment
Majola is one of millions of patients in South Africa affected by U.S. President Donald Trump’s global foreign aid freeze, raising worries about HIV patients defaulting on treatment, infection ...